Glucagon-like peptide-1 receptor agonists (GLP-1RAs), beyond their glucoregulatory and weight-loss benefits, exhibit potential cardioprotective effects that may be relevant to AF
Simple and mundane tasks such as climbing stairs or walking long distances suddenly become effortless, and theres an overall improvement in your physical health
If your provider prescribed a GLP-1 agonist for you, know that while it can decrease appetite and promote weight loss, your provider may take a comprehensive approach that also includes exercise, diet changes, behavioral modifications, or sometimes even bariatric surgery
The authors concluded: Further research is needed to determine if there is a true cause and effect relationship in the association identified in this investigation and to understand the trade-offs between the benefits and risks of GLP-1 RAs. Also in June, the European Medicines Agency safety committee warned that semaglutide (active substance in Ozempic, Rybelsus and Wegovy) may cause the NAION optic neuropathy described earlier in this article
Everyones like, Oh, smaller portions, like shut the f up
[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Wharton S., Davies M., Dicker D., et al